HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic significance of acute renal injury in acute tumor lysis syndrome.

Abstract
Acute tumor lysis syndrome (ATLS) caused by the destruction of malignant cells leads to metabolic abnormalities, which may either remain isolated (biological ATLS) or subsequently lead to renal dysfunction (clinical ATLS). We compared hospital and 6-month survival in patients with ATLS with hematological malignancies with or without acute renal injury. Sixty-three patients (median age, 50 years; range, 32-64) were included with ATLS. Twenty-eight had no ARI (including 17 (61%) who subsequently required dialysis) whereas 35 had an ATLS-related ARI (including 31 (89%) who required dialysis). Acute leukemia (n = 28) and lymphoma (n = 30) were the main malignancies. All patients had high tumor burdens. Hospital and 6-month mortality rates were significantly lower in patients without ARI (7% and 21%, respectively) than in the ATLS-related renal injury group (51% and 66%). After adjustment for acute disease severity, presence of ARI at ICU admission was associated with higher hospital mortality (odds ratio, 10.41; 95% confidence interval, 2.01-19.170; p = 0.005) and 6-month mortality (odds ratio, 5.61; 95% confidence interval, 1.64-54.66; p = 0.006), compared to patients without renal injury. Our study suggests that in patients with ATLS, ICU management when acute renal injury is present is associated with higher short- and long-term mortality.
AuthorsMichael Darmon, Isabelle Guichard, François Vincent, Benoit Schlemmer, Elie Azoulay
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 51 Issue 2 Pg. 221-7 (Feb 2010) ISSN: 1029-2403 [Electronic] United States
PMID20001238 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Acute Kidney Injury (complications, therapy)
  • Adult
  • Aged
  • Female
  • Hematologic Neoplasms (complications)
  • Hospital Mortality
  • Humans
  • Intensive Care Units (statistics & numerical data)
  • Logistic Models
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Prognosis
  • Renal Dialysis
  • Survival Analysis
  • Survival Rate
  • Tumor Lysis Syndrome (complications, mortality, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: